The outcome of chronic viral infections, which affect millions of people worldwide, is greatly dependent on CD4 + T cells. Here we showed that T cell-specific ablation of the common interleukin-6 (IL-6) family receptor, gp130, profoundly compromised virusspecific CD4
INTRODUCTION
Chronic viral infections such as human immunodeficiency virustype 1 (HIV-1), hepatitis C virus (HCV), and hepatitis B virus (HBV) affect hundreds of millions of people worldwide (Virgin et al., 2009 ). Viral persistence is associated with decreased numbers of both virus specific CD4 + and CD8 + T cells along with a progressive loss of their ability to kill infected targets and produce important effector molecules such as interferon-g (IFN-g), tumor necrosis factor-a (TNF-a), and interleukin-2 (IL-2) (Letvin and Walker, 2003; Rehermann and Nascimbeni, 2005) . Indeed, upregulation of multiple inhibitory surface molecules including PD-1, LAG-3, and Tim3 (Barber et al., 2006; Blackburn et al., 2009; Wherry et al., 2007) , along with IL-10 (Brooks et al., 2006; Ejrnaes et al., 2006) , during chronic infection contributes to the hierarchical loss of function seen in virus-specific T cells. In addition, transforming growth factor-b (TGF-b) signaling limits the numbers of virus-specific T cells (Boettler et al., 2012; Garidou et al., 2012; Tinoco et al., 2009 ). These features appear commonly among actively replicating chronic viruses in humans and other animals (Clerici et al., 1994; Cumont et al., 2007; Day et al., 2006; Le Clerc et al., 2009; Rigopoulou et al., 2005; Urbani et al., 2006) , and this highly immunosuppressive environment prevents viral eradication and makes the host extremely susceptible to secondary infections and cancers.
Individuals control persistent viruses to differing extents, ranging from elite controllers of HIV-1 and acutely resolving HCV patients to fast HIV and HCV progressors (Letvin and Walker, 2003; Rehermann and Nascimbeni, 2005) . This varied degree of viral control associates with different quality and quantity of CD4 + and CD8 + T cell responses (Virgin et al., 2009 ). In particular, CD4 + T cells are central for several aspects of antiviral responses. The outcome of HIV infection depends critically on the rate and the extent of virus-specific CD4 + T cell expansion with decreased CD4 + T cell numbers tightly correlating with progression into AIDS (Porichis and Kaufmann, 2011; Virgin and Walker, 2010) . Similarly, spontaneous recovery from HCV and HBV infection associates with vigorous CD4 + and CD8 + T cell responses while CD4 + T cell depleted chimpanzees fail to clear HBV or HCV and develop severe liver disease (Rehermann and Nascimbeni, 2005) . CD4 + T cells are also essential to control the persistent variant of lymphocytic choriomeningitis virus, LCMV Clone 13 (Cl13), in a mouse model of chronic viral infection (Battegay et al., 1994; Matloubian et al., 1994a) . Recently, this model has been used to uncover CD4 + -derived IL-21 as vital for CD8 + (but not CD4 + ) T cell maintenance during late chronic infection (Elsaesser et al., 2009; Frö hlich et al., 2009; Yi et al., 2009) . IL-21 has also been found to positively correlate with lower viral loads in HIV-and HCV-infected patients (Chevalier et al., 2011; Iannello et al., 2010; Yue et al., 2010) . In addition, LCMV Cl13 infection results in the late accumulation of virusspecific T follicular helper (Tfh) cells (Fahey et al., 2011; Harker et al., 2011) , a process subsequently observed during HBV, HCV, simian immunodeficiency virus (SIV), and HIV infection (Feng et al., 2011 (Feng et al., , 2012 Lindqvist et al., 2012; Petrovas et al., 2012) . This is in part dependent on IL-6 signaling on CD4 + T cells during the later stages of chronic infection and results in enhanced virus-specific antibody responses and viral control (Harker et al., 2011; Petrovas et al., 2012) .
IL-6 is the archetypal member of the IL-6 cytokine family, which includes IL-11, IL-27, leukemia inhibitory factor (LIF), cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M (OSM) (Silver and Hunter, 2010) . The members of the IL-6 family can exert both unique and overlapping functions through their common use of the constitutively expressed transmembrane receptor gp130, which dimerizes with cytokine-specific receptors on cytokine binding. Given this conserved signaling pathway, we speculated that along with IL-6, other members of the IL-6 family of cytokines may have potent effects on T cell function during chronic infection. Supporting this, IL-6 deficiency does not affect in vivo IL-21 during chronic infection; however, ex vivo IL-6 stimulation of CD4 + T cells from LCMV Cl13 infected mice causes rapid expression of Il21 (Harker et al., 2011) , suggesting the presence of functional redundancies for IL-21 induction.
To bypass such functional redundancies, we examined the effect of genetic ablation of Il6st (which encodes gp130) in T cells during persistent LCMV Cl 13 infection in mice. In the absence of gp130 on T cells, mice were incapable of controlling infection, had a profound reduction in the numbers of virus-specific CD8 + and CD4 + T cells, and compromised antibody responses. In contrast to CD8 + T cells, which appeared functionally unaltered by gp130 deficiency, Il6st À/À CD4 + T cells also had greatly reduced Tfh proportions and IL-21 production. Although the CD8 + T cell defects were in most part extrinsic, direct gp130 signaling on CD4 + T cells was essential for their survival and function at late stages of chronic LCMV infection. We identified IL-27 as the gp130 signaling cytokine promoting CD4 + T cell survival and that (similarly to IL-6) was capable of rapidly inducing IL-21 ex vivo but was redundant for its in vivo production. Our data indicate that gp130 signaling cytokines play a vital role during late stages of chronic viral infection including regulation of CD4 + T cell survival and IL-21 production to orchestrate antiviral responses.
RESULTS

Gp130 Signaling on T Cells Was Essential for Control of Chronic Viral Infection
To investigate the role of T cell-specific gp130 signaling on control of a chronic viral infection, we infected Cd4-cre Il6st Figure S1 available online). Initial and peak viremia were identical; however, mice lacking T cell gp130 showed a complete failure to control viremia while WT mice had significantly reduced viral loads from day 45 postinfection (p.i.) onward ( Figure 1A ). By day 130 p.i., virus was readily detectable across multiple tissues in Il6st À/À mice while it was only detected in the brain of WT animals ( Figure 1B ). Gp130 deficiency did not affect the clearance of acute LCMV Armstrong infection (data not shown). In contrast to the decline in viremia that we previously observed in WT and Il6 À/À mice between days 30 and 45 p.i., mice deficient in T cell gp130 showed little or no decline in viremia between these two time points ( Figure 1A ) (Harker et al., 2011) . These results demonstrated that gp130 signaling on T cells played a critical role in controlling chronic (but not acute) LCMV infection in vivo. In addition, the fact that viremia was higher in mice lacking gp130 compared with Il6
mice suggested that gp130 signaling cytokines (other than IL-6) significantly contributed to viral containment during chronic LCMV infection.
T Cell gp130 Signaling Promotes CD8 + and CD4 + T Cell Accumulation at Late Stages of Chronic Infection IL-6 deficiency does not affect the total numbers of virus specific CD8 + or CD4 + T cells throughout chronic LCMV infection (Harker et al., 2011 Figure 2B ).
''Antigen experienced'' PD-1 + CD4 + T cells in the blood also showed normal development in Cd4-cre Il6st fl/fl mice on days 9
and 15 p.i., but a significantly reduced number was seen from day 30 onward compared to WT mice ( Figure 2C ). The number of H2-A b LCMV GP 67-77 -specific CD4 + T cells was also dramatically reduced in the absence of gp130 signaling, with a profound reduction of virus specific cells observable at day 30 p.i. (16% of WT numbers), but unaltered numbers at day 9 p.i. (Figure 2D ). Combined these results show that gp130 cytokines, while not required for priming and initial expansion of virus specific T cell responses, are essential for their accumulation at late stages of chronic LCMV infection. Given that neither CD4 + nor CD8 Viral load was monitored in the serum throughout infection (A) and the indicated tissues at day 135 p.i. by immunofocus assay (B). Data is representative of two experimental repeats; n R 4 mice per group with mean ± SEM depicted. This figure is supported by Figure S1 .
IL-6 independent gp130 signaling in the maintenance of virusspecific CD8 + and CD4 + T cell numbers at later stages of chronic infection. T cells but also a hierarchical (IL-2 > TNF-a > IFN-g) loss of function of those cells that remain . The loss of gp130 signaling on T cells did not, however, alter the level of functional exhaustion in virus specific CD8 + T cells ( Figure S2 ).
Gp130 Deletion in T Cells
During chronic LCMV infection there is a progressive increase in the proportion of virus specific CD4 + Tfh cells (Fahey et al., 2011; Harker et al., 2011) . In this context, IL-6 signaling is required for maximal upregulation of Bcl6 and Tfh cell numbers but is not required for these cells to produce IL-21 ( + T regulatory cells (Tregs) was increased at day 30, but not day 9, p.i. in the absence of gp130 signaling ( Figure S3D ). However, the total number of Treg cells was unaltered in gp130-deficient animals at both time points studied. Stimulation of CD4 + T cells from both WT and Cd4-cre Il6st fl/fl mice at day 9 p.i. with LCMV GP 67-77 peptide resulted in moderate IFN-g production and low IL-21 secretion as previously reported ( Figure 3A Figure 3C ). These results indicated that gp130 signaling is not only essential for CD4 + T cell maintenance and differentiation, but it is also necessary for them to produce IL-21 at late stages of chronic LCMV infection. The defective IL-21 production in the absence of T cell gp130 signaling contrasted with unchanged amounts observed in Il6 À/À mice (Harker et al., 2011) . This implied the presence of gp130 cytokines (other than IL-6) that regulated this fundamental CD4 + T cell function during an established chronic viral infection.
Immunity T Cell gp130 Signaling in Chronic Infection
Consistent with defective CD4 + T cell accumulation and function we observed dramatic effects on humoral immunity in Cd4-cre Il6st fl/fl compared to WT mice. This included lower numbers of germinal center B cells, reduced concentrations of LCMVspecific immunoglobulin (Ig), IgG, IgG1, and IgG2a antibodies and weakened avidity of LCMV-specific IgG ( Figure S4) . These results further demonstrate the need for gp130 signaling in CD4 T cells for optimal antibody responses.
Cell-Intrinsic gp130 Is Essential for Virus Specific CD4 + T Cells Accumulation and IL-21 Production
The loss of T cell-specific gp130 signaling, although not affecting T cell development or the initial expansion of either virus-specific CD4 + or CD8 + T cell responses during LCMV infection, had significant impact on the number of virus-specific T cells at later stages of infection (day 30 p.i.) and prevented viral control. Figure S5A ). The bias to WT cells seen was similar to that described in mixed chimeras reconstituted with equal proportions of WT and Il6ra À/À deficient BM cells (Harker et al., 2011) suggesting that IL-6 played a role in the development of T cells under competitive conditions.
At day 30 after LCMV Cl13 infection, the numbers of H2-D b LCMV GP 33-41 CD8 + T cells were reduced in the gp130-deficient compartment versus WT in some, but not all, mixed chimeras, reaching a p value equal to 0.0649 ( Figure 4A Figure S3 .
ure 4B). Tfh cell differentiation in the remaining virus-specific CD4 + T cells, and total CD4 + T cells, was also dramatically reduced ( Figure S5B ). Consistently, there was low or undetectable expression of Bcl6 in virus-specific CD4 + T cells in the absence of gp130, whereas Prdm1 (Blimp-1) expression was lower but detectable ( Figure S5C ). Deletion of T cell-specific Il6st during intestinal nematode infection, in otherwise highly susceptible IL-10-deficient animals, resulted in enhanced Th2 CD4 + T cell and reduced Th1 and Th17 CD4 + T cell, mediated immunity, and accelerated parasite expulsion and protection (Fasnacht et al., 2009) . In this study, we saw slight reductions in the expression of both Tbx21 (T-bet) (Th1) and Gata3 (Th2) in virus-specific CD4 + T cells in the absence of
Il6st, but no change in the balance of the immune response (Figures S5E-S5F ), whereas we saw little to no Rorc expression indicating few or no Th17 cells were present (data not shown). This difference is most likely as a result of the different infectious systems used, because this is the first report of the overall role of T cell-specific gp130 signaling during a viral infection. The proportion of IFN-g-producing cells that were also producing IL-21 was significantly reduced in the absence of gp130, indicating that cell intrinsic gp130 signaling is required for IL-21 production after ex vivo peptide stimulation ( Figure 4C ). Accordingly, amounts of Il21 transcript measured directly ex vivo were undetectable in Il6st À/À I-A b GP 67-77 CD4 + T cells from mixed chimeras, whereas they were readily detectable in their WT counterparts ( Figure 4D Figure 5C ). In contrast, analysis of bromodeoxyuridine (BrdU) incorporation revealed that the proliferation of virus-specific CD4 T cells was enhanced (likely as a result of a compensatory effect) in Cd4-cre Il6st fl/fl mice, but similar in WT and Il6st À/À cells in the mixed chimeric setting ( Figures 5D and 5E Figure 5F ). Overall, these data indicate that cell-intrinsic gp130 signaling was fundamental in promoting CD4 + T cell survival at late stages of chronic LCMV infection.
IL-27 Drives Accumulation of Virus-Specific CD4 + T
Cells and Promotes IL-21 Production Ex Vivo
To determine which of the cytokines that use gp130 was involved in promoting CD4 + T cell survival and IL-21 production, we examined their individual capacity to phosphorylate the downstream molecules STAT-1 and STAT-3. In CD4 + T cells taken from naive animals IL-6, IL-27, OSM, and LIF were all capable of STAT-3 phosphorylation, while IL-6 and IL-27 also caused phosphorylation of STAT-1 ( Figure 6A ). As we have shown previously, ex vivo IL-6 stimulation of transgenic LCMV GP 61-80 -specific CD4 + T (Smarta) cells taken from WT mice 18 days after LCMV Cl13 infection also caused rapid phosphorylation of STAT-3 ( Figure 6A ) (Harker et al., 2011 repeats from pooled samples of n R 4 mice, with mean ± SEM depicted. This figure is supported by Figure S4 .
Immunity T Cell gp130 Signaling in Chronic Infection
pronounced phosphorylation of STAT-1. Stimulation with LIF, IL-11, and OSM phosphorylated neither STAT-1 nor STAT-3. Because IL-27 was the only tested member of the IL-6 family of cytokines, other than IL-6, capable of directly signaling on virus-specific CD4 + T cells during LCMV Cl13 infection, we evaluated its cell-intrinsic effects on CD4 + T cells in vivo. In WT:Il27ra À/À mixed bone marrow chimeras, unlike Cd4-cre Il6st fl/f and Il6ra À/À mixed bone marrow chimeras, the Il27ra À/À CD4 + T cell compartment was similar in proportion to the WT CD4 + T cell compartment after reconstitution ( Figure S6A ). There was, however, a slight bias toward WT CD8 T cells and Il27ra Figure 6B ). However, IL-21 production in the remaining Il27ra À/À virus-specific CD4 + T cells was similar to that seen in WT CD4 + T cells ( Figure 6C ) as was the proportion of virus-specific CD4 T cells that expressed Bcl6 and differentiated into Tfh cells ( Figures S6B and S6C) .
Stimulation of polyclonal virus-specific PD-1 + CD4 + T cells taken 18 days after LCMV Cl13 infection with recombinant IL-27 resulted in rapid upregulation of Il21, with the amount of transcript peaking at 6 hr after stimulation, whereas as we have previously shown, IL-6 also caused the upregulation of Il21 transcript, but this peaked at 12 hr after stimulation (Figure 6D) . Increased Il21 transcript was also seen 6 hr after IL-27 stimulation in Smarta CD4 + T cells ( Figure 6E ). Ex vivo IL-27 stimulation also lead to upregulation of Bcl6 expression in PD-1 + and Smarta CD4 + T cells ( Figures S6D and S6E) . Together, these data show that IL-27 plays an essential role in the accumulation of virus-specific CD4 + T cells at late stages during chronic viral infections. Furthermore, both IL-27 and IL-6 were capable of rapidly upregulating IL-21 in virus-specific CD4 + T cells but 
Finally, we assessed the importance of IL-27R signaling in overall viral control. Il27ra À/À mice exhibited significantly higher viremia than their WT counterparts as early as between days 5 and 9 p.i. (Figure 7D ). Given that deletion of Il6st exclusively in T cells did not affect early control of LCMV Cl13 ( Figure 1A) , it is likely that this initial difference in viral loads is a consequence of deficient IL-27 signaling in non-T cells. Infection of Il27ra
mice also resulted in a failure of the long term control of persistent LCMV with virus detectable in the blood and a range of tissues up to 130 days after infection, when the majority of WT animals had cleared virus ( Figure 7D and 7E) . Altogether, these data indicate that IL-27 signaling plays a critical role in the maintenance of CD4 + T cell numbers and viral control during chronic viral infection in vivo.
DISCUSSION
The presence and function of antigen-specific CD4 + T cells is vital for optimal immune responses in many infectious contexts, but especially during chronic viral infections. Here we showed that direct gp130 signaling was vital for the survival of virus-specific CD4 + T cells and for their key functional properties such as IL-21 production during chronic viral infection in vivo. Further, we demonstrated that different members of the IL-6 family have both unique and redundant roles in this process; IL-27 was essential for CD4 + T cell accumulation, while we have previously
shown that IL-6 plays a dominant role in the differentiation of Tfh cells. On the other hand, although both IL-6 and IL-27 were capable of promoting IL-21 production ex vivo they were redundant in vivo, suggesting that multiple gp130 signaling cytokines secure optimal IL-21 production.
Higher concentrations of IL-21 are associated with lower viral loads in HIV and HCV infections (Chevalier et al., 2011; Iannello et al., 2010; Yue et al., 2010) and with an increased success rate in vaccination of chronically infected individuals (Pallikkuth et al., 2011) . STAT-3 is heavily associated with the transcription of Il21 (Kaplan et al., 2011) . Engagement of gp130 with cytokinespecific receptors results in rapid phosphorylation of STAT-3 (Ernst and Jenkins, 2004) and our study revealed a vital role for gp130 signaling in IL-21 production in vivo at late stages of chronic LCMV infection. STAT-3 binds not only at the ll21 promoter but also at Batf and Maf loci (Durant et al., 2010) , two other transcription factors known to promote IL-21 (Hiramatsu et al., 2010; Schraml et al., 2009) , suggesting multiple molecular pathways through which gp130 signaling might trigger and maintain IL-21 production. Once produced, IL-21 itself could act in an autocrine fashion by further phosphorylating STAT-3. Both IL-6 and IL-27, were capable of inducing STAT-3 phosphorylation and Il21 transcription in virus-specific CD4 + T cells taken from chronically infected mice but none of the other gp130 cytokines (C) PD-1 + CD4 + T cells were enumerated in the blood by flow cytometry.
(D and E) Viral load was determined in the blood (D) at various time points and in tissues (E) at day 130 after infection. Data is representative of n = 2 experimental repeats of n = 5 mice per group, with mean ± SEM depicted.
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T Cell gp130 Signaling in Chronic Infection tested (i.e., IL-11, OSM, and LIF) were capable of phosphorylating STAT-3 in LCMV-specific CD4 + T cells. Given the essential nature of gp130 but nonessential roles for IL-6R or IL-27R, our data strongly suggests that IL-6 and IL-27 act redundantly to promote IL-21 production in CD4 + T cells. Although our study focused on chronic viral infection, it is conceivable that gp130 signaling may trigger IL-21 production in the context of autoimmune diseases such as diabetes, multiple sclerosis, and Sjogren's syndrome where IL-21 is associated with increased pathology (Jones et al., 2009; McGuire et al., 2011; Spolski et al., 2008) . IL-27-gp130 signaling promoted the survival of virus-specific CD4 + T cells at late stages of chronic LCMV infection. However, it was dispensable for CD4 + T cell accumulation early after infection, indicating that other signaling pathways must be involved in inducing CD4
+ T cell proliferation and survival at these time points. Likely candidates are the common gc cytokines such as IL-2, IL-7, and IL-15, which are potent mediators of both naive and activated T cell survival and proliferation (Rochman et al., 2009) . Indeed provision of either IL-2 or IL-7 is sufficient to rescue mice from LCMV Cl13 infection Pellegrini et al., 2011) . Many of their effects are mediated by activation of STAT-5, which also blocks the differentiation of Tfh cells (Johnston et al., 2012; Nurieva et al., 2012) . Tfh cells accumulate in LCMV Cl13 infected mice during late stages of infection, at a time when IL-2 production is compromised by T cell exhaustion (Brooks et al., 2005) , which may indicate reduced gc-STAT5 signaling, leaving CD4 + T cells reliant on gp130 signaling for survival. In CD8 + T cells, although is not required for initial expansion, it is essential for the formation of long-lived memory cells, providing evidence that T cells can progressively alter their STAT requirements for accumulation and survival (Cui et al., 2011) . Both IL-6 and IL-21 can phosphorylate STAT-3, however, whereas only IL-27 signaling results in enhanced CD4 + T cell survival in vivo. Meanwhile, only IL-27 phosphorylated STAT-1 in virus-specific CD4 + T cells, suggesting that STAT-1 could promote CD4 + T cell survival late during chronic infection. Phosphorylation of STAT-1 by IL-27 in this context is most likely due to its use of WSX-1, which contains a box 1 janus kinase (JAK) domain capable of activating the STAT family independently of gp130 (Sprecher et al., 1998) . In many contexts, STAT-1 is thought to activate an antiproliferative, proapoptotic pathway in T cells (Bromberg et al., 1996; Gil et al., 2006; Tanabe et al., 2005) ; thus, exploration of STAT-1's functions at late stages of infection is worthy of further investigation. IL-27 is also known to phosphorylate STAT-4 and STAT-5, although less potently than it does STAT-1, both of which have potent effects on CD4 + T cell differentiation and could have prosurvival effects via these pathways (Kaplan, 2005; Lucas et al., 2003) . The loss of IL-27R signaling across the whole mouse resulted in reduced viral control and a slight increase in the number of virus-specific CD4 + T cells at early stages of viral infection.
Because this was not observed when Il6st was conditionally ablated in T cells, nor in mixed chimeras generated from either Il27ra À/À or Cd4-cre Il6st fl/fl mice, it suggests that IL-27 signaling also has a vital non-T cell role in antiviral immunity early during LCMV Cl13 infection. Fitting with this, effective IL-27 signaling has also been shown in natural killer cells, NK T cells, B cells, and macrophages (Imamichi et al., 2008; Villarino et al., 2005; Yoshimoto et al., 2004) ; however, the effects of IL-27 signaling on cells other than CD4 + T cells during chronic viral infection is yet to be explored. It is possible that the presence of higher viral loads early during LCMV Cl13 infection plays a role in the increased virus-specific CD4 + T cell numbers observed in LCMV Cl13 infected Il27ra À/À mice at day 9 p.i. Alternatively, this could be a consequence of IL-27's regulation of cell populations that directly influence CD4 + T cell expansion (e.g., antigen-presenting cells). Our data therefore not only show the importance of IL-27 in the maintenance of virus-specific CD4 + T cell responses and viral control during chronic viral infection in vivo but also highlight the complex and significant role that IL-27 plays in different aspects of immune responses and the need to use models that allow discrimination of cell-intrinsic versus -extrinsic effects (such as mixed bone marrow chimeras) in the exploration of these processes. IL-27 signaling has previously been implicated in controlling Tfh cells numbers after vaccination (Batten et al., 2010) , whereas we have previously observed that IL-6 plays an essential role in Tfh cells differentiation during chronic viral infection (Harker et al., 2011) . In this context, IL-27 appears to be essential for the survival of virus-specific CD4 + T cells, the majority of which are Tfh cells, but does not appear to control Tfh cell differentiation or Bcl6 expression. Complete loss of gp130-mediated signaling, however, results in loss of both virus-specific CD4 + T cells and Tfh cell differentiation. This leads us to hypothesize that during chronic viral infection, IL-6 is vital for Tfh cell differentiation, whereas IL-27 is required for their ongoing survival. The number of CD8 + and CD4 + T cells is critical in determining the outcome of chronic viral infections in mice and humans (Rehermann and Nascimbeni, 2005; Virgin and Walker, 2010; Virgin et al., 2009 ). CD4 + T cells are often not required for the initial generation of virus-specific CD8 + T cell responses, but they are vital for the maintenance and quality of these cells and are also fundamental for B cell responses (Matloubian et al., 1994b; Shedlock and Shen, 2003) . Notably, the use of vaccines that target both the cytotoxic and humoral arms of the immune system, such as the RV144 prime-boost HIV vaccine trial (Benmira et al., 2010) , have demonstrated the efficacy of this approach compared to prior vaccines that aimed to target a single aspect of immunity. Our data places gp130 signaling at the center of CD4 + T cell responses within the highly immunosuppressive environment of an established chronic viral infection and highlights the potential of this pathway as a target for simultaneously empowering both humoral and cellular immunity in this context.
EXPERIMENTAL PROCEDURES
Mice and Viral Stocks WT C57BL/6 mice, C57BL/6 CD45. Generation of BM Chimeras BM chimeras were generated via transfer of a 50:50 ratio of BM cells from Cd4-cre Il6st fl/fl or Il27ra À/À mice and C57BL/6 CD45.1 + mice into lethally irradiated C57BL/6 CD45.1 + as described previously (Harker et al., 2011) .
LCMV-Specific Antibody ELISAs
LCMV-specific ELISAs and avidity assays were done as we and others have previously described (Hammond et al., 1997; Harker et al., 2011) .
Flow Cytometry
Flow cytometry was done as previously described (Tinoco et al., 2009 ). The following fluorochrome labeled antibodies purchased from ebioscience or BD biosciences were used to stain blood or spleen cells: anti-CD8-pacific blue, -CD4-pacific blue, -CD19-PE, -CD38-Alexa Fluor 700, -GL7-FITC, -PD1-PE-Cy7, -ICOS-PE, -SLAM-FITC or PE-Cy7, -CD45.2-APC-Cy7, -CD45.1-PerCy5.5, -CD200-PerCP-eFlour 610, -IFN-g-APC, -TNF-a-FITC, -IL-2-PE, -CD107a-FITC, -CD107b-FITC, Annexin-V-PE, and -B220-FITC. CXCR5, FoxP3, and Bcl6 (BD, K112-91) staining were done as previously described (Harker et al., 2011) . Cells were acquired by using the Digital LSR II flow cytometer (Becton Dickinson, San Jose, CA). To quantify incorporation of BrdU by tetramer + T cells, we injected mice with 2 mg of BrdU (Sigma-Aldrich) 16 hr before analysis and splenocytes stained with BrdU Flow kit (BD Biosciences) following the manufacturer instructions. Staining for fluorescence assisted cell sorting was conducted in an identical fashion and cells were isolated on a FACSAria (Becton Dickinson, San Jose, CA) to >95% purify. Flow cytometric data were analyzed with FlowJo software (TreeStar, CA).
Ex Vivo T Cell Stimulation
For MHC class-I-restricted GP 33-41 peptide (2 mg/ml) or MHC class-II restricted GP 67-77 (5 mg/ml) stimulation and staining were carried out as we have previously described (Tinoco et al., 2009) . For polyclonal stimulation, we used PMA (10 ng/ml) and ionomicyn (0.5 mg/ml) in place of peptide. For intracellular IL-21 staining, cells were permeabilized with saponin and incubated with 1:25 dilution of IL-21RhFc (R&D Systems) for 30 min at 4 C, washed twice and stained with 1:200 anti-human Fc-PE (BD PharMingen). For phosphorylation of STATs, 1,000 CD45.1 + Smarta CD4 + T cells were transferred i.v. 1 day prior to infection with 2 3 10 6 pfu of LCMV Cl13. At 18 days p.i., splenocytes were isolated, rested, for 2 hr at 37 C, and stimulated with 50 ng/ml of recombinant human IL-6 (National Cancer Institute) or mouse IL-11, IL-27, LIF (eBioscience), or oncostatin M (Cell Signaling). Cells were fixed after 30 min, and pSTAT staining was done according to manufacturer's instructions (BD).
Real-Time RT-PCR Total RNA was extracted from splenocytes by using RNeasy kits (QIAGEN), and reverse transcribed into cDNA by using superscript III RT (Invitrogen). cDNA quantification was performed by using SYBR Green PCR kits (Applied Biosystems) and a real-time PCR Detection System (ABI). Primers for the genes assessed are described in (Harker et al., 2011) . 
